Order Article Reprints

Lin TA, Fuller CD, Verma V, Mainwaring W, Espinoza AF, Miller AB, Jethanandani A, Pasalic D, Das P, Minsky BD, et al. Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials. Cancers. 2020; 12(9):2636. https://doi.org/10.3390/cancers12092636

Lin, Timothy A., Clifton David Fuller, Vivek Verma, Walker Mainwaring, Andres F. Espinoza, Austin B. Miller, Amit Jethanandani, Dario Pasalic, Prajnan Das, Bruce D. Minsky, and et al. 2020. "Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials" Cancers 12, no. 9: 2636. https://doi.org/10.3390/cancers12092636

Lin, T. A., Fuller, C. D., Verma, V., Mainwaring, W., Espinoza, A. F., Miller, A. B., Jethanandani, A., Pasalic, D., Das, P., Minsky, B. D., Thomas, C. R., Jr., Fogelman, D. R., Subbiah, V., Subbiah, I. M., & Ludmir, E. B. (2020). Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials. Cancers, 12(9), 2636. https://doi.org/10.3390/cancers12092636